Novo Biosolutions, a Bioprocess consulting and contract research and product development company was founded in 2008 by Dr. Sanjay Jain in the Greater Boston area. Novo Biosolutions provides services to Biotechnology and Pharmaceutical companies in support of product development, project management, and business development. The main focus of Novo Biosolutions is to provide CMC services to companies engaged in Biologics product development including human vaccines, monoclonal antibodies, and recombinant Biosimilar products.
Dr. Sanjay Jain has over 25 years of experience in the field of Biotechnology, Applied Genetics, and Industrial Microbiology. He has worked for several Biotechnology/ Pharmaceutical companies, including multinational companies, such as Astra-Zeneca, Cephalon Inc. and Shire Pharmaceuticals. He served as Chief Scientific Officer (Vaccine R&D), Panacea Biotec Ltd. New Delhi (India). He has also worked at academic and non-profit organizations, such as Worcester Polytechnic Institute and PATH Malaria Vaccine Initiative. Most recently, Sanjay was technical Program Advisor for PATH Malaria Vaccine Initiative. During his career, he has supported several IND applications and a BLA, for FDA approval of recombinant protein products.
Sanjay received his Ph.D. degree in Microbiology, from Paul Sabatier University, Toulouse, France. After completing his doctoral degree and prior to moving to USA, he spent two years at GBF- National Biotechnology Institute, Braunschweig, Germany. He has published several research articles in peer reviewed journals, as well as organized and presented at national and international scientific conferences.
Emerging market experience
Protein expression (Escherichia coli, Filamentous fungi, Yeast: Saccharomyces cerevisiae, Pichia pastoris, Mammalian and Insect cell culture system)
Development of recombinant protein vaccines
Development of polysaccharide conjugate vaccines
Process development (Fed-batch and Perfusion process development)
Scale-up and tech transfer for large scale non-GMP production (partner organizations)
GMP cell banking and GMP production for Toxicology and Clinical studies (partner organizations)
Novo Biosolutions has been working with clients as a liaison between companies in India, USA, and Europe for technical development and/ or business development opportunities. We have established business relationships with organizations/ companies in India for technology licensing and/or co-development of recombinant biologic products, as well as identifing new business opportunities to expand product and technology portfolios. We have also represented CMO companies, who provide a range of Biologics contract services in GMP cell banking, Viral clearance, as well as Microbial and Cell-culture product development.
Vaccines, Recombinant proteins, Enzymes, Antibodies, BiosimilarsCase studies
Recombinant Escherichia coli process for the soluble expression of carrier protein used in polysaccharide conjugate vaccines
Recombinant Pichia pastoris process development and pilot scale production of a secreted protein